Skip to main content
. Author manuscript; available in PMC: 2008 Apr 30.
Published in final edited form as: Dev Cell. 2007 Nov;13(5):623–634. doi: 10.1016/j.devcel.2007.10.005

Figure 5. Sar1 is enriched at ER exit sites in CLSD patient cells.

Figure 5

Thin sections were analyzed by immuno-electron microscopy using anti-Sar1 antibody and gold labeled secondary antibody. The average number of gold particles per tubular-vesicular profile is given with standard errors. The number of images evaluated is in parentheses. * p<0.001 for homozygote versus heterozygote and unrelated wild type (Student t-Test).